Organization
University Hospital CHUV, Lausanne, Switzerland
2 abstracts
Abstract
A phase 2/3 study of fianlimab, cemiplimab, plus chemotherapy versus cemiplimab plus chemotherapy in first-line treatment of advanced non-small cell lung cancer.Org: High Technology Medical Center, University Clinic Ltd., Tbilisi, Georgia, LTD High Technology Hospital Med Center, Batumi, Georgia, JSC Vian Caraps Medline, European University, Tbilisi, Georgia, University of Tennessee Medical Center, Knoxville, TN, Mid Florida Cancer Centers, Orange City, FL,
Abstract
Feasibility of treatment with another CDK4/6 inhibitor after severe ribociclib liver toxicity.Org: EHC, Morges, Switzerland, University Hospital 12 de Octubre, Institut Curie, Saint Cloud, France, Centre GF Leclercq,